Aromatic L-Amino Acid Decarboxylase
Showing 1 - 25 of >10,000
Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Trial in Shanghai (VGN-R09b)
Recruiting
- Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
-
Shanghai, No. 1678, Dongfang Road, Pudong New Area, Shanghai, ChinaShanghai Children's Medical Center Affiliated to Shanghai Jiao T
Mar 9, 2023
Aromatic L-Amino Acid Decarboxylase Deficiency Trial in Angers, Toulouse (Plasmatic 3-O-Methyldopa dosage)
Recruiting
- Aromatic L-Amino Acid Decarboxylase Deficiency
- Plasmatic 3-O-Methyldopa dosage
-
Angers, France
- +1 more
Aug 10, 2022
AADC/TDC in Advanced Parkinson's Disease
Not yet recruiting
- Parkinson Disease
- (no location specified)
Dec 9, 2022
Aromatic Amino Acid Decarboxylase Deficiency Trial in Taipei (AAV2-hAADC)
Active, not recruiting
- Aromatic Amino Acid Decarboxylase Deficiency
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 15, 2021
Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Trial in Taipei (gene therapy)
Active, not recruiting
- Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
- gene therapy
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 4, 2021
Baby Detect : Genomic Newborn Screening
Recruiting
- Congenital Adrenal Hyperplasia
- +126 more
-
Liege, Wallonia, BelgiumCRMN, Hôpital La Citadelle
Jan 24, 2023
Type I Diabetes Trial in Birmingham (Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active
Completed
- Type I Diabetes
- Placebo GABA and Placebo GAD-alum
- +2 more
-
Birmingham, AlabamaChildren's of Alabama
May 2, 2022
Phenylketonurias Trial in Birmingham (Casein, L-amino acids, CGMP-AA)
Active, not recruiting
- Phenylketonurias
- Casein
- +2 more
-
Birmingham, West Midlands, United KingdomUniversity Hospitals Birmingham NHS Foundation Trust
Jul 25, 2023
Parkinson Disease Trial in Shimotsuke (Cohort1, Cohort2)
Terminated
- Parkinson Disease
- Cohort1
- Cohort2
-
Shimotsuke, Tochigi, JapanJichi Medical University
Aug 7, 2019
Parkinson's Disease Trial in United States (VY-AADC02, Sham (Placebo) Surgery)
Active, not recruiting
- Parkinson's Disease
- VY-AADC02
- Sham (Placebo) Surgery
-
Irvine, California
- +19 more
Mar 17, 2022
Long-term Extension Study for Participants of Prior VY-AADC01
Enrolling by invitation
- Parkinson's Disease
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 17, 2022
Pregnancy Related Trial in Vancouver (Aromatic Amino Acid Intake)
Completed
- Pregnancy Related
- Aromatic Amino Acid Intake
-
Vancouver, British Columbia, CanadaClinical Research and Evaluation Unit
Sep 22, 2020
Vitamin D Deficiency Trial in Shreveport (Vitamin D, Placebo, Vitamin D + L-cysteine)
Recruiting
- Vitamin D Deficiency
- Vitamin D
- +3 more
-
Shreveport, LouisianaLouisiana State University Health Shreveport
Sep 2, 2022
Phenylketonurias Trial in Kobenhavn, Bristol, Birmingham (CGMP protein substitute, L-amino acid protein substitute)
Active, not recruiting
- Phenylketonurias
- CGMP protein substitute
- L-amino acid protein substitute
-
Kobenhavn, Denmark
- +2 more
Sep 15, 2022
Diabetes, Diabetic Peripheral Neuropathy, Diabetic Foot Ulcer Trial in Columbia (Lovaza, L-Arginine Powder, Vitamin C)
Enrolling by invitation
- Diabetes Mellitus
- +2 more
- Lovaza
- +2 more
-
Columbia, South CarolinaPrisma Health
Jan 10, 2023
Cerebral Palsy, Genetic Disease, Developmental Delay Trial in Ljubljana (NGS)
Completed
- Cerebral Palsy
- +3 more
- NGS
-
Ljubljana, SloveniaUniversity Children's Hospital, University Medical Centre Ljublj
Nov 1, 2022
Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)
Not yet recruiting
- Localized Osteosarcoma
- +3 more
- Cabozantinib S-malate
- +7 more
- (no location specified)
Jan 4, 2023
Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease Trial in United States (VY-AADC01)
Completed
- Idiopathic Parkinson's Disease
- +8 more
-
San Francisco, California
- +3 more
Mar 17, 2022
Neurosciences Trial (Précurseur de la dopamine, antagoniste D2, PLACEBO)
Not yet recruiting
- Neurosciences
- Précurseur de la dopamine
- +2 more
- (no location specified)
Feb 1, 2023
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
AADC Deficiency Trial in Israel, Taiwan, United States (Eladocagene Exuparvovec)
Recruiting
- AADC Deficiency
- Eladocagene Exuparvovec
-
Palo Alto, California
- +6 more
Aug 4, 2022
Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc Trial in Stanford (Durvalumab, Carboplatin, Pemetrexed)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Durvalumab
- +5 more
-
Stanford, CaliforniaStanford University
Oct 27, 2022
Amino Acid, Body Weight Changes, Skin Manifestations Trial in Pavia (L-glutamine, L-arginine and calcium
Completed
- Amino Acid
- +4 more
- L-glutamine, L-arginine and calcium beta-hydroxy-beta-methylbutyrate
- Placebo
-
Pavia, ItalyAzienda di Servizi alla Persona
Jan 7, 2021
Parkinson Disease Trial in Lille (A-dopamine, optimized oral treatment)
Recruiting
- Parkinson Disease
- A-dopamine
- optimized oral treatment
-
Lille, FranceHopital Roger Salengro, CHU Lille
Oct 11, 2022